Anhui Huaheng Biotechnology Co., Ltd.SSE: 688639

(688639)"Anhui Huaheng Biotechnology Co., Ltd."Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

· Issued by Anhui Huaheng Biotechnology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688639 · · 2 pages · Chinese

Summary by 6ix AI

The filing details the verification process conducted by the Remuneration and Appraisal Committee of the Board of Directors concerning the disclosed list of incentive recipients. The committee confirmed that all listed participants meet the necessary qualifications and do not fall under any disqualifying conditions as per relevant regulations.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688639anhui-huaheng-biotechnology-co-ltdreview-opinion-and-statement-on-the-public-disclosure-of-the-list-of-participants-for-the-initial-grant-under-the-companys-2026-restricted-share-incentive-plan-issued-by-the-remuneration-and-appraisal-committee-of-the-board-of-directors

Release

Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Anhui Huaheng Biotechnology Co., Ltd. on 6ix

Story so far

Earlier from Anhui Huaheng Biotechnology

Later from Anhui Huaheng Biotechnology

All Anhui Huaheng Biotechnology news releases